{"DataElement":{"publicId":"3624628","version":"1","preferredName":"Leukemia Malignant Neoplasm Diagnosis Stratification Code","preferredDefinition":"the coded value representing the onset or diagnosis of leukemia used in the process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"3624624v1.0:3624625v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"3624624","version":"1","preferredName":"Leukemia Malignant Neoplasm Diagnosis Stratification","preferredDefinition":"information related to the process of classifying patients into strata as part of the randomization process or for purposes of data analysis based on the diagnosis of leukemia.","longName":"3624622v1.0:3369424v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"3624622","version":"1","preferredName":"Leukemia Malignant Neoplasm","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C3161:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD75FAA6-D87C-0C17-E040-BB89AD436D15","latestVersionIndicator":"Yes","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"ONEDATA","dateModified":"2012-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3369424","version":"1","preferredName":"Diagnosis Stratification","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C15220:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7EF2A14-BE86-D9A1-E040-BB89AD435F52","latestVersionIndicator":"Yes","beginDate":"2012-02-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-02-01","modifiedBy":"ONEDATA","dateModified":"2012-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD75FAA6-D88A-0C17-E040-BB89AD436D15","latestVersionIndicator":"Yes","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3624625","version":"1","preferredName":"Leukemia Diagnosis Stratification Code","preferredDefinition":"the coded value representing the onset of leukemia used in the process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"3624625v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"de novo","ValueMeaning":{"publicId":"2793777","version":"1","preferredName":"de novo","longName":"2793777","preferredDefinition":"(dih NO-vo) In cancer, the first occurrence of cancer in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"de novo","conceptCode":"C28354","definition":"Anew, afresh, or over again from the beginning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59284AA5-B2EF-43D4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-13","modifiedBy":"ZHWENDY","dateModified":"2022-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD75FAA6-D8D2-0C17-E040-BB89AD436D15","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"ONEDATA","dateModified":"2012-11-01","deletedIndicator":"No"},{"value":"2","valueDescription":"treatment related and/or AML arising from antecedent hematologic disease","ValueMeaning":{"publicId":"3624626","version":"1","preferredName":"treatment related and/or AML arising from antecedent hematologic disease","longName":"3624626","preferredDefinition":"Treatment related and/or AML arising from antecedent hematologic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD75FAA6-D8DD-0C17-E040-BB89AD436D15","latestVersionIndicator":"Yes","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD75FAA6-D8F6-0C17-E040-BB89AD436D15","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"ONEDATA","dateModified":"2012-11-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD75FAA6-D8B4-0C17-E040-BB89AD436D15","latestVersionIndicator":"Yes","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"DWARZEL","dateModified":"2013-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Onset of leukemia","type":"Preferred Question Text","description":"Onset of leukemia","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD75EAAD-FE02-B4FB-E040-BB89AD43194C","latestVersionIndicator":"Yes","beginDate":"2012-11-01","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-11-01","modifiedBy":"SBR","dateModified":"2013-06-28","changeDescription":" Moved content from CTEP to SWOG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}